FDA has approved imaging system to help detect cervical cancer.
BD says reducing false-negative findings and interpretation errors is the system's goal. That's accomplished through "state-of-the-art" guided screening technology for rapidly relocating the fields of view that the system identifies as likeliest to contain cells of interest.
For more information, visit the company's Web site at http://www.bd.com/.
Removing parental consent reduces delays in adolescent abortion care
February 12th 2025A new study links the removal of parental consent requirements for abortion in Massachusetts to significantly earlier gestational age at the time of the procedure, highlighting the impact of reduced barriers on timely reproductive care.
Read More